March 23, 2025 - 10:21

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) have taken a significant step by sending a letter to the U.S. Food and Drug Administration (FDA). This letter, supported by over 20 prominent organizations and providers from various sectors of healthcare, emphasizes the urgent need for the FDA to implement and enforce federal regulations concerning compounding practices.
The call to action comes in the wake of recent shortages of GLP-1 medications, which are crucial for the treatment of obesity and related conditions. These shortages have raised serious concerns about patient access to essential therapies. The coalition argues that without stricter oversight and regulation of compounded medications, patients may face continued disruptions in their treatment options.
Healthcare leaders are advocating for a timely response from the FDA to ensure that patients receive the medications they need without interruption, highlighting the importance of regulatory frameworks in safeguarding public health.
February 5, 2026 - 01:11
UNC Health Pardee opens outpatient infusion site at Henderson centerA new outpatient infusion center is now open in Henderson County, offering residents a more convenient location for essential treatments. The facility, operated by UNC Health Pardee, is situated on...
February 4, 2026 - 04:02
Health officials report 29 new measles cases, one in Sumter CountyHealth officials in South Carolina have confirmed a significant expansion of a measles outbreak, announcing 29 new cases since late last week. This surge brings the total number of cases connected...
February 3, 2026 - 10:27
S.F. public health dept. has to cut $17 million. No one is happy.San Francisco`s Department of Public Health is facing a mandated $17 million budget reduction, a move that has sparked significant outcry from the community organizations that rely on its funding....
February 2, 2026 - 18:41
This global health leader praises Trump's aid plan -- and gears up to beat malariaBill Steiger, a seasoned figure with senior roles in both the George H.W. Bush and Trump administrations, is now leading the charge against one of the world`s oldest diseases. As the new head of...